123Tom's TA study group

[F1ash]

I haven't computed their burn rate but here is how I view the "lay of the land".

It's a solid bet that they can't find an acceptable partnership to pay for their next phase 2/3 Alzheimer's study.

They had authorization to raise $50 million dollars from their LPC line of credit agreement. They only had 6.7 million shares to do that with because it would have diluted current shareholders beyond 20% to issue more shares. They quickly burned up over 5 million of those authorized shares and only raised ~$25 million. So they asked for and received permission from shareholders to authorize 5 million more shares to raise the remainder.

No need to do either of those things if a partnership is in the making imho.

This company bought a drug that was sitting on the shelf for so long that the patent is about to expire. They tested it in house and claim to have discovered its magical qualities.

They have yet to run a "real" trial which includes placebo controls and blinding, yet the market cap is 1/4 of a billion dollars.

They presented graphs that seem to show the last phase of their trial did something no other Alzheimer's drug has ever done yet they extended the trial by another year. Something there does not add up imho.

They have named their trials extensions of extensions. Almost seems like a game of three card Monte to me.

Hope I'm wrong for shareholders sake though.

Probably a good one to trade because they are careful to never really run a real trial that could fail.

All imho only!